{"entity":{"id":"da-trial-trailrunner-alz3","kind":"trial","name":"TRAILRUNNER-ALZ 3","aka":[],"tldr":"TRAILRUNNER-ALZ 3 is a Phase 3 programme for remternetug. Recruiting status changes; check ClinicalTrials.gov.","summary":"An interventional amyloid-antibody study. Listing here is not a recommendation to enrol. Discuss eligibility only with a clinician and the study site.","status":"recruiting","asOf":"2026-09-21","links":[{"label":"ClinicalTrials.gov NCT06653153","url":"https://clinicaltrials.gov/study/NCT06653153"}],"tags":["dementia-atlas"],"related":[],"cancers":["alzheimers-disease"],"sections":[],"technologies":[],"targets":[],"drugs":["da-remternetug"],"companies":["da-lilly"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT06653153","phase":"3","setting":"Early Alzheimer’s disease","sponsor":"Eli Lilly","outcomes":[]},"route":"/trials/da-trial-trailrunner-alz3/","neighbours":{"cancer":[{"id":"alzheimers-disease","kind":"cancer","name":"Alzheimer’s disease","route":"/diagnoses/alzheimers-disease/"}],"drug":[{"id":"da-remternetug","kind":"drug","name":"Remternetug","route":"/drugs/da-remternetug/"}],"company":[{"id":"da-lilly","kind":"company","name":"Eli Lilly","route":"/companies/da-lilly/"}]}}